Alzheimer's drug candidate may be first to prevent disease progression
A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS One.
View ArticleCommonly used dementia drugs can help more patients with Alzheimer's
The dementia drug donepezil (Aricept), already widely used to treat mild to moderate Alzheimer's disease, can also help in moderate to severe patients, according to a report funded by the UK Medical...
View ArticleAricept helps moderate to severe Alzheimer's too
Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's doing any...
View ArticleAlzheimer's drug sharply criticized by medical experts
Watching Alzheimer's disease steal away the memory, talents and very selves of its victims is hard enough for the people who love them. But a new pill formulated by a respected pharmaceutical company...
View ArticleAlzheimer's drug shows promise in early trial
(HealthDay News) -- Researchers say an investigational drug helped improve memory, language, attention and other mental skills in people with early Alzheimer's disease.
View ArticleConsumer group sues FDA over Aricept safety
(AP)—A consumer group pressing the Food and Drug Administration to remove the highest dose of an Alzheimer's disease drug from the market is suing the agency for "foot-dragging."
View ArticleFor drug makers, new 3-D control opens wealth of options
A team of scientists anchored at Yale University has demonstrated a new, highly versatile approach for quickly assembling drug-like compounds, establishing a broad new route to drug discovery and...
View ArticleScientists develop drug that slows Alzheimer's in mice
A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. The...
View ArticleJapan firm starts Down's therapy test
A Japanese pharmaceutical company said Monday it will begin therapeutic testing of a drug it hopes will slow the decline in quality of life for some people with Down's syndrome.
View Article
